advertisement

WGA Rescources

Nakamura M 11

Showing records 1 to 11 | Display all abstracts from Nakamura M

84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Yamamoto K
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Mori S
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Kokubun T
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Murai Y; Ueda K
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Sato K
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Sakamoto M
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Akaishi T; Shimazaki A
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Kurimoto T; Yamada-Nakanishi Y; Yamada-Nakanishi Y
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Nakamura M; Shiga Y
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Nakamura M
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Tsuda S; Omodaka K; Saya H; Nakazawa T
Scientific reports 2019; 9: 19288

Issue 21-1

Change Issue


advertisement

Oculus